RxDoctor Payments Data

Lindsey Keeney, PA

Physician Assistant · Ripley, WVNPI 1871977355

Payments from drug & device makers

$1,068in general payments, 2019–2025

Across 76 payments — averaging $14.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$496
  • Novo Nordisk$163
  • Pfizer$139
  • Boehringer Ingelheim$48
  • Lilly USA, LLC$41
  • Medtronic$31
  • plus $150 from 8 others

What the payments were for

  • Food & beverage$1,068100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,068 in reported general payments places this provider in the 75th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Medicare billing

Part B allowed, 2024
$641
Medicare patients
28
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide37$80,058
FarxigaDapagliflozin Propanediol56$70,487
EliquisApixaban49$60,420
JardianceEmpagliflozin28$44,412
OzempicSemaglutide37$34,794
MounjaroTirzepatide15$27,327
JanuviaSitagliptin Phosphate15$24,735
TradjentaLinagliptin13$17,806
SymbicortBudesonide/Formoterol Fumarate31$14,200
Incruse ElliptaUmeclidinium Bromide25$13,384
Spiriva HandihalerTiotropium Bromide16$12,779
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$9,785
Spiriva RespimatTiotropium Bromide16$8,004
Dexlansoprazole DrDexlansoprazole12$4,547
BreynaBudesonide/Formoterol Fumarate15$4,472

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$163$114,85174 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$48$70,22357 claims
PfizerEliquis$139$60,42049 claims
Lilly USA, LLCMounjaro$41$27,32715 claims
GSKIncruse Ellipta, Shingrix$30$15,94940 claims
AbbVieSynthroid$496$97519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Ripley

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →